Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,225.00
Bid: 2,200.00
Ask: 2,250.00
Change: -80.00 (-3.57%)
Spread: 50.00 (2.273%)
Open: 2,250.00
High: 2,160.00
Low: 2,160.00
Prev. Close: 2,240.00
CRW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement

8 Nov 2016 07:00

RNS Number : 5525O
Craneware plc
08 November 2016
 

Craneware plc

("Craneware", "the Group" or the "Company")

AGM Statement

 

8 November 2016 - Craneware plc (AIM: CRW.L), the leader in Value Cycle solutions for the US healthcare market, will be holding its Annual General Meeting today at 10am. At the meeting, Keith Neilson, CEO of the Company, will make the following statement:

 

"We continue to see positive results in the first few months of the current fiscal year. In September we announced the move back into double-digit revenue and adjusted EBITDA growth. With the impact of sales made during FY16 starting to contribute to revenue, combined with our sales pipeline and activity, we see that momentum continuing in the current year.

 

"The US healthcare market continues its evolution towards value-based care with a critical dependency on accurate financial and operating data. We are investing in our Value Cycle product suite to ensure we have the solutions to provide hospitals with tools that deliver insight into these areas of their operations, expanding our market opportunity and increasing our strategic value within our market.

 

"2017 will see some exciting developments for Craneware with the launch of Trisus Claims Informatics, the first product to be launched on our newly developed cloud-based Trisus Enterprise Value Platform; followed shortly thereafter by the launch of Trisus Patient Payment, a new fourth gateway product, operating within the patient access and engagement area.

 

"We are also making good progress within our newly formed Group business, Craneware Healthcare Intelligence, which is focused on the development of cost analytics software for the US healthcare industry.

 

"With our expanded offering and market opportunity, high levels of revenue visibility and favourable market backdrop, we believe we are just at the start of a long-term growth trajectory and are confident in the future success of Craneware."

 

 

For further information, please contact:

 

Craneware plc

Peel Hunt

Alma

 

+44 (0)131 550 3100

+44 (0)20 7418 8900

+44 (0)208 004 4218

 

Keith Neilson, CEO

Dan Webster

Caroline Forde

 

Craig Preston, CFO

Adrian Trimmings

Hilary Buchanan

 

 

George Sellar

Robyn McConnachie

 

 

 

 

 

About Craneware

 

Craneware enables healthcare providers to improve margins and enhance patient outcomes so they can continue to provide quality outcomes for all.

 

Craneware is the leader in automated value cycle solutions that help US healthcare provider organisations discover, convert and optimise assets to achieve best clinical outcomes and financial performance. Founded in 1999, Craneware has its headquarters in Edinburgh, Scotland with offices in Atlanta, Boston and Phoenix employing over 200 staff. Craneware's market-driven, SaaS solutions normalise disparate data sets, bringing in up-to-date regulatory and financial compliance data to deliver value at the points where clinical and operational data transform into financial transactions, creating actionable insights that enable informed tactical and strategic decisions. To learn more, visit craneware.com and thevaluecycle.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMDGBDBRUGBGLR
Date   Source Headline
23rd May 20237:00 amRNSTransaction in Own Shares
22nd May 20237:00 amRNSTransaction in Own Shares
19th May 20237:00 amRNSTransaction in Own Shares
18th May 20237:00 amRNSTransaction in Own Shares
17th May 20237:00 amRNSTransaction in Own Shares
16th May 20237:02 amRNSTransaction in Own Shares
12th May 20239:21 amRNSTransaction in Own Shares
11th May 20237:00 amRNSTransaction in Own Shares
5th May 202312:35 pmRNSNotification of Major Holdings
28th Apr 20237:00 amRNSTransaction in Own Shares
27th Apr 20237:00 amRNSTransaction in Own Shares
26th Apr 20237:00 amRNSTransaction in Own Shares
25th Apr 20237:00 amRNSTransaction in Own Shares
24th Apr 20237:00 amRNSTransaction in Own Shares
21st Apr 20237:00 amRNSTransaction in own shares
19th Apr 20237:00 amRNSTransaction in Own Shares
18th Apr 20237:00 amRNSTransaction in Own Shares
17th Apr 20237:00 amRNSTransaction in Own Shares
14th Apr 20237:00 amRNSBlock Listing Announcement
14th Apr 20237:00 amRNSTransaction in Own Shares
13th Apr 20237:18 amRNSTransaction in Own Shares
12th Apr 20237:00 amRNSShare Buyback Programme
24th Mar 202311:02 amRNSDividend Currency Election
14th Mar 20237:00 amRNSDirector Share Purchase
6th Mar 20237:00 amRNSInterim Results
13th Feb 20235:15 pmRNSHolding(s) in Company
1st Feb 20233:25 pmRNSDirector Share Purchase
27th Jan 20237:31 amRNSDirector Share Purchase
19th Jan 20232:05 pmRNSSecond Price Monitoring Extn
19th Jan 20232:00 pmRNSPrice Monitoring Extension
19th Jan 20237:00 amRNSTrading Update and Notice of Results
25th Nov 20222:14 pmRNSDividend Currency Election
25th Nov 20229:16 amRNSHolding(s) in Company
21st Nov 202211:40 amRNSGrant of Long Term Incentive Plan Awards
15th Nov 20222:25 pmRNSResult of AGM
15th Nov 20227:00 amRNSAGM Statement and Board Appointment
4th Nov 20221:33 pmRNSHolding(s) in Company
14th Oct 20225:22 pmRNSPosting of Annual Report and Notice of AGM
14th Oct 20227:00 amRNSBlock listing Interim Review
11th Oct 20224:19 pmRNSHolding(s) in Company
10th Oct 202211:10 amRNSHolding(s) in Company
10th Oct 202211:02 amRNSHolding(s) in Company
23rd Sep 20229:06 amRNSVesting of Long Term Incentive Plan Awards
21st Sep 20224:14 pmRNSExercise of Share Options
20th Sep 20227:00 amRNSFinal Results
14th Sep 20223:29 pmRNSChange of Date of Final Results
26th Jul 20227:00 amRNSFY22 Trading Update and Notice of Results
7th Jul 20226:13 pmRNSHolding(s) in Company
27th Apr 20221:00 pmRNSBoard Appointment
14th Apr 202212:35 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.